Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A Virus
Open Access
- 1 March 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Computational Biology
- Vol. 8 (3), e1002418
- https://doi.org/10.1371/journal.pcbi.1002418
Abstract
Understanding the mechanisms involved in long-term persistence of humoral immunity after natural infection or vaccination is challenging and crucial for further research in immunology, vaccine development as well as health policy. Long-lived plasma cells, which have recently been shown to reside in survival niches in the bone marrow, are instrumental in the process of immunity induction and persistence. We developed a mathematical model, assuming two antibody-secreting cell subpopulations (short- and long-lived plasma cells), to analyze the antibody kinetics after HAV-vaccination using data from two long-term follow-up studies. Model parameters were estimated through a hierarchical nonlinear mixed-effects model analysis. Long-term individual predictions were derived from the individual empirical parameters and were used to estimate the mean time to immunity waning. We show that three life spans are essential to explain the observed antibody kinetics: that of the antibodies (around one month), the short-lived plasma cells (several months) and the long-lived plasma cells (decades). Although our model is a simplified representation of the actual mechanisms that govern individual immune responses, the level of agreement between long-term individual predictions and observed kinetics is reassuringly close. The quantitative assessment of the time scales over which plasma cells and antibodies live and interact provides a basis for further quantitative research on immunology, with direct consequences for understanding the epidemiology of infectious diseases, and for timing serum sampling in clinical trials of vaccines. Recent studies evidenced the existence of long-lived plasma-cells which could play a major role in the long-term persistence of antibodies after infection or vaccination. A mathematical model, accounting for two plasma-cells populations (short and long-lived), was developed to analyze data from two long-term follow-up studies in patients vaccinated with hepatitis A inactivated vaccines. Parameter estimates confirmed the importance of three time scales to explain the decay of antibody levels: the antibodies lifespan (around one month), the short-lived plasma cells lifespan (several months) and the long-lived plasma cells lifespan (decades). This study also highlighted the need of more frequent observations during the first year post-vaccination to estimate accurately the different parameters governing the long-term antibody dynamics.Keywords
This publication has 34 references indexed in Scilit:
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunityImmunological Reviews, 2010
- Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responsesGynecologic Oncology, 2009
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensThe New England Journal of Medicine, 2007
- Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccineVaccine, 2007
- Estimation of Population Pharmacokinetic Parameters of Saquinavir in HIV Patients with the MONOLIX SoftwareJournal of Pharmacokinetics and Pharmacodynamics, 2007
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- Long‐term persistence of antibodies induced by vaccination and safety follow‐up, with the first combined vaccine against hepatitis A and B in children and adults*Journal of Medical Virology, 2001
- Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicityJournal of Medical Virology, 1994
- Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long‐term antibody persistenceJournal of Medical Virology, 1994
- Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis AVaccine, 1993